Skip To Main Content
Xianying Meng on Muck Rack

Xianying Meng

As seen in: Frontiers, MDPI, Royal Society of Chemistry
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Xianying

Contact Xianying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Precision management of medullary thyroid carcinoma: a dynamic framework integrating biomarkers, genotyping, and risk stratification

|
By Shaohua Guo, Kehui Wu, Yaoqi Wang, Shuai Yang, Lei Wang, Tianyu Chen, Xianying Meng, Chengzheng Jia
| Frontiers
Abstract Medullary thyroid carcinoma (MTC) is a heterogeneous neuroendocrine malignancy in which outcomes are shaped by tumor burden, locoregional spread, and molecular context. Precision management therefore requires explicit separation of hereditary MTC driven by germline RET variants from presumed sporadic disease, and a structured integration of serum biomarkers, imaging, pathology, and genotype.
Open in Who Shared Issue with article?

Hierarchical Nanostructures of Iron Phthalocyanine Nanowires Coated on Nickel Foam as Catalysts for the Oxygen Evolution Reaction

|
By Xianying Meng, Peng Yu, Mingyi Zhang
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Lipid‐mediated Delivery of CD47 siRNA Aids JQ1 in Ensuring Simultaneous Downregulation of PD-L1 and CD47 and Hence Antitumor Immunotherapy Efficacy

|
By Yong Li, Xianying Meng, Guang X. Chen, Yue Hou
| Royal Society of Chemistry Verified
Lipid‐mediated Delivery of CD47 siRNA Aids JQ1 in Ensuring Simultaneous Downregulation of PD-L1 and CD47 and Hence Antitumor Immunotherapy Efficacy Yong LI, Xianying Meng, Guang Chen, Yue Hou, Xuan Wu, Jialiang Wang, Xiuxiu Cong, Kuirong Mao, Chenxi Wu, Hongmei Chen, Xu Sun, Jingjing Zhou, Ye Wang, Yong-guang Yang and Tianmeng Sun Abstract Cancer immunotherapy using immune checkpoint blockade has become an attractive treatment option for patients with different cancers.
Open in Who Shared Issue with article?
See all 4 articles